- Home
- REGCO vs HUMAW Comparison
REGCO vs HUMAW Comparison
Compare REGCO & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REGCO
- HUMAW
- Stock Information
- Founded
- REGCO N/A
- HUMAW 2004
- Country
- REGCO United States
- HUMAW United States
- Employees
- REGCO 500
- HUMAW 220
- Industry
- REGCO
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- REGCO
- HUMAW Health Care
- Exchange
- REGCO Nasdaq
- HUMAW Nasdaq
- Market Cap
- REGCO N/A
- HUMAW N/A
- IPO Year
- REGCO N/A
- HUMAW N/A
- Fundamental
- Price
- REGCO $22.55
- HUMAW $0.48
- Analyst Decision
- REGCO
- HUMAW
- Analyst Count
- REGCO 0
- HUMAW 0
- Target Price
- REGCO N/A
- HUMAW N/A
- AVG Volume (30 Days)
- REGCO N/A
- HUMAW 14.2K
- Earning Date
- REGCO N/A
- HUMAW 03-21-2025
- Dividend Yield
- REGCO N/A
- HUMAW N/A
- EPS Growth
- REGCO N/A
- HUMAW N/A
- EPS
- REGCO N/A
- HUMAW N/A
- Revenue
- REGCO N/A
- HUMAW N/A
- Revenue This Year
- REGCO N/A
- HUMAW N/A
- Revenue Next Year
- REGCO N/A
- HUMAW N/A
- P/E Ratio
- REGCO N/A
- HUMAW N/A
- Revenue Growth
- REGCO N/A
- HUMAW N/A
- 52 Week Low
- REGCO N/A
- HUMAW $1.18
- 52 Week High
- REGCO N/A
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- REGCO 53.32
- HUMAW N/A
- Support Level
- REGCO $22.35
- HUMAW N/A
- Resistance Level
- REGCO $22.62
- HUMAW N/A
- Average True Range (ATR)
- REGCO 0.19
- HUMAW 0.00
- MACD
- REGCO 0.03
- HUMAW 0.00
- Stochastic Oscillator
- REGCO 61.70
- HUMAW 0.00
About REGCO Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 482 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.